Yabing Guo
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 13
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver physiology and pathology 2
-
- Hepatitis B Virus Studies 8
- Co-authors
- Jinlin Hou (11 shared papers)Jian Sun (5 shared papers)Zhanhui Wang (4 shared papers)Hong Yang (1 shared paper)Xiuhui Li (1 shared paper)Shujuan Wen (1 shared paper)Jin Zhang (1 shared paper)Li Liu (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)The Journal of Infectious Diseases (2 papers)BMC Medicine (1 paper)Antiviral Research (1 paper)Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Yabing Guo
39 papers receiving 548 citations
Peers
Comparison fields: 5 of 79
- Hepatology 224
- Epidemiology 227
- Pharmacology 38
- Health Informatics 3
- Pathology and Forensic Medicine 37
Countries citing papers authored by Yabing Guo
This map shows the geographic impact of Yabing Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Guo more than expected).
Fields of papers citing papers by Yabing Guo
This network shows the impact of papers produced by Yabing Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Guo. The network helps show where Yabing Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yabing Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 137 | |
| 2 | 2021 | 63 | |
| 3 | 2014 | 60 | |
| 4 | 2020 | 32 | |
| 5 | 2022 | 29 | |
| 6 | 2021 | 23 | |
| 7 | 2021 | 20 | |
| 8 | 2022 | 18 | |
| 9 | 2017 | 18 | |
| 10 | 2021 | 16 | |
| 11 | 2024 | 16 | |
| 12 | 2021 | 15 | |
| 13 | 2008 | 13 | |
| 14 | [Influence of adefovir dipivoxil or telbivudine monotherapy on renal function of patients with chronic hepatitis B]. | 2012 | 11 |
| 15 | 2010 | 9 | |
| 16 | Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen. | 2003 | 9 |
| 17 | 2019 | 6 | |
| 18 | [A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B]. | 2005 | 6 |
| 19 | 2021 | 5 | |
| 20 | 2024 | 5 |
About Yabing Guo
Yabing Guo is a scholar working on Hepatology, Epidemiology, Oncology, Cancer Research and Surgery, having authored 40 papers that have together received 555 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Hepatitis B Virus Studies (8 papers), Colorectal Cancer Treatments and Studies (5 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Liver physiology and pathology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Medical and Biological Ozone Research (2 papers). The work is most often cited by research in Hepatology (224 citations), Epidemiology (227 citations), Pharmacology (38 citations), Health Informatics (3 citations) and Pathology and Forensic Medicine (37 citations). Yabing Guo has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Jinlin Hou, Jian Sun, Zhanhui Wang, Hong Yang, Xiuhui Li, Shujuan Wen, Jin Zhang, Li Liu, Xue‐Jun Guo and Jinzhang Chen. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Infectious Diseases, BMC Medicine, Antiviral Research and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.